Clinical Trials in Salt Lake City

Showing 9301-9320 of 16,694 trials

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

NCT02369159

This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of pediatric subjects with acute uncomplicated influenza.

Influenza

BioCryst Pharmaceuticals137 participantsStarted Mar 2015

Shreveport, Louisiana, United States • Dayton, Ohio, United States • Smithfield, Pennsylvania, United States +7 more locations

TERMINATED< 1 mile

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

NCT01652157

This is a long-term study in cystic fibrosis patients who are participating in the Cystic Fibrosis Patient Registry to assess the occurrence and risk factors for a rare bowel disorder called fibrosing colonopathy (narrowing of the large intestine). Patients will be followed at their regular clinical care visits over a 10-year period and approached if they develop symptoms of fibrosing colonopathy for collection and use of further detailed information.

Fibrosing Colonopathy

AbbVie17 participantsStarted Jul 2012

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +120 more locations

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Find Trials by Condition in Salt Lake City

Longitudinal Surveillance Study of the 4-SITE Lead/Header System

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Tanezumab in Osteoarthritis of the Knee

Efficacy and Mechanisms of Technology-based Behavioral Interventions

Ceprotin Treatment Registry

ADVATE Post Authorization Safety Surveillance

SynCardia 70cc TAH-t for Destination Therapy (DT)

A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

Early Elimination of Premature Ventricular Contractions in Heart Failure

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis

Natural History Study of Children With Metachromatic Leukodystrophy

Mortality Reduction After Oral Azithromycin: Morbidity Study

Ultrasound-Guided Percutaneous Peripheral Nerve Stimulation: A Department of Defense Funded Multicenter Pilot Study